According to a recent LinkedIn post from AcuityMD, the company participated as a Gold Sponsor at LSI USA ’26, a conference focused on MedTech innovation and investment trends. The post highlights that the event brought together founders, investors, and industry leaders, emphasizing the continued importance of in‑person networking for healthcare technology stakeholders.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that MedTech funding dynamics are shifting toward fewer but larger deals, with venture investors concentrating on companies that can demonstrate validated technology and clearer paths to revenue. For AcuityMD, association with this investor-focused forum and its emphasis on commercialization readiness may reinforce its positioning as a data-driven partner for growth-stage MedTech companies.
By underscoring access to investors, thought leadership from figures such as Rob Brown and Aaron Smith, and exposure to high-intent founders, the post indicates that the company is active within capital formation and deal-making circles in the sector. This visibility could support future business development, deepen relationships with well-funded MedTech clients, and potentially enhance AcuityMD’s role in a market where funding selectivity appears to be increasing.